Search Results | Showing 1 - 10 of 105 results for "Biotech" |
| | | Perennial Partners has agreed with Australian Unity Funds Management Limited (AUFM) to take over the investment management of the latter's Future of Healthcare Fund. AUFM will also step down as trustee of the fund, with Perennial taking over as trustee. ... |
| | | | Uniseed has joined forces with major Australian universities, doubling the number of research partners in the fund. Monash University has joined Uniseed as its full partner, along with the University of Newcastle, University of Technology Sydney, Western ... |
| | | | ... Investing offshore also allows the fund to access investments that you can't easily access in Australia, whether it's biotech or other sectors," he said. Nevertheless, JPMorgan's report clarified that while large funds heavily invested in ... |
| | | | ... of a predicted boom in what Hannon calls the "S-Curve" of market adoption. Innovators: Hydrogen, EVs, green buildings, biotech, agtech and food innovation were classified as "innovators" - adoption is currently slow as only a small group of innovators ... |
| | | | ... $1.2 million; Redbubble has $1.7 million deposited; Freelancer has about US$2.35 million; Laybuy has less than US$10,000; biotech Tissue Repair has US$2.18 million; DUG Technology has about US$5.1 million; and Life360 said its exposure is expected to ... |
| | | | ... ASX-listed companies. The 35 stocks that make up the portfolio are from a variety of industries including commodities, mining, biotech, pharmaceuticals, tourism, finance and software. It includes Qantas Airways, Sonic Healthcare, Computershare and the ... |
| | | | Andrew and Nicola Forrest's Tattarang has backed new biotech venture capital group Tenmile to the tune of $250 million. The company will focus on supporting founders and companies building new, impactful health techbology and biotech solutions. Already ... |
| | | | Sydney-based Inventia Life Science has announced the super fund's direct investment as it develops, manufactures and distributes the RASTRUM 3D bioprinter. The bioprinter enables the scale-up production of 3D cell cultures for research and 3D cells ... |
| | | | UniSuper, the $106 billion industry fund, has made an investment with a venture capital fund manager. The fund has invested $75 million with early-stage commercialisation fund manager, Uniseed. The investment will feed into UniSuper's sustainable investment ... |
| | | | Chris Hall has taken on a new role with a biotechnology company after finishing up at Ellerston Capital last month. BiomeBank has announced the appointment of Chris Hall as the new chair for the clinical stage biotechnology company. He served as chief ... |
|
